Serafina Chimirri

628 total citations
11 papers, 482 citations indexed

About

Serafina Chimirri is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Serafina Chimirri has authored 11 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 2 papers in Cellular and Molecular Neuroscience and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Serafina Chimirri's work include Drug-Induced Adverse Reactions (3 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers) and Epilepsy research and treatment (2 papers). Serafina Chimirri is often cited by papers focused on Drug-Induced Adverse Reactions (3 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers) and Epilepsy research and treatment (2 papers). Serafina Chimirri collaborates with scholars based in Italy and United Kingdom. Serafina Chimirri's co-authors include Emilio Russo, Giovambattista De Sarro, Caterina Palleria, Rita Citraro, Francesca Scicchitano, Rossana Aiello, Luca Gallelli, Stefania Esposito, Roy Upton and Benjamin J. Whalley and has published in prestigious journals such as Neuroscience, Epilepsia and Behavioural Brain Research.

In The Last Decade

Serafina Chimirri

11 papers receiving 467 citations

Peers

Serafina Chimirri
Serafina Chimirri
Citations per year, relative to Serafina Chimirri Serafina Chimirri (= 1×) peers Ali Rıza Ocak

Countries citing papers authored by Serafina Chimirri

Since Specialization
Citations

This map shows the geographic impact of Serafina Chimirri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serafina Chimirri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serafina Chimirri more than expected).

Fields of papers citing papers by Serafina Chimirri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serafina Chimirri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serafina Chimirri. The network helps show where Serafina Chimirri may publish in the future.

Co-authorship network of co-authors of Serafina Chimirri

This figure shows the co-authorship network connecting the top 25 collaborators of Serafina Chimirri. A scholar is included among the top collaborators of Serafina Chimirri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serafina Chimirri. Serafina Chimirri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Russo, Emilio, Antonio Leo, Rosalia Crupi, et al.. (2016). Everolimus improves memory and learning while worsening depressive- and anxiety-like behavior in an animal model of depression. Journal of Psychiatric Research. 78. 1–10. 22 indexed citations
2.
Aiello, Rossana, Rosalia Crupi, Antonio Leo, et al.. (2014). Long-term betamethasone 21-phosphate disodium treatment has distinct effects in CD1 and DBA/2 mice on animal behavior accompanied by opposite effects on neurogenesis. Behavioural Brain Research. 278. 155–166. 6 indexed citations
3.
Citraro, Rita, Serafina Chimirri, Rossana Aiello, et al.. (2014). Protective effects of some statins on epileptogenesis and depressive‐like behavior in WAG/Rij rats, a genetic animal model of absence epilepsy. Epilepsia. 55(8). 1284–1291. 56 indexed citations
4.
Palleria, Caterina, Christian Leporini, Serafina Chimirri, et al.. (2013). Limitations and obstacles of the spontaneous adverse drugs reactions reporting: Two “challenging” case reports. Journal of Pharmacology and Pharmacotherapeutics. 4(1_suppl). S66–S72. 86 indexed citations
5.
Carbone, Claudia, et al.. (2013). A questionnaire-based study in Calabria on the knowledge of off-label drugs in pediatrics. Journal of Pharmacology and Pharmacotherapeutics. 4(1_suppl). S51–S54. 17 indexed citations
6.
Chimirri, Serafina, Rossana Aiello, Laura Mumoli, et al.. (2013). Vertigo/dizziness as a Drugs' adverse reaction. Journal of Pharmacology and Pharmacotherapeutics. 4(1_suppl). S104–S109. 50 indexed citations
7.
Chimirri, Serafina, Francesco Ursini, Saverio Naty, et al.. (2013). Interactions among Low Dose of Methotrexate and Drugs Used in the Treatment of Rheumatoid Arthritis. Advances in Pharmacological Sciences. 2013. 1–8. 28 indexed citations
8.
Russo, Emilio, Francesca Scicchitano, Benjamin J. Whalley, et al.. (2013). Hypericum perforatum: Pharmacokinetic, Mechanism of Action, Tolerability, and Clinical Drug-Drug Interactions. Phytotherapy Research. 28(5). 643–655. 131 indexed citations
9.
Russo, Emilio, Serafina Chimirri, Rossana Aiello, et al.. (2013). Lamotrigine positively affects the development of psychiatric comorbidity in epileptic animals, while psychiatric comorbidity aggravates seizures. Epilepsy & Behavior. 28(2). 232–240. 30 indexed citations
10.
Russo, Emilio, Francesca Scicchitano, Rita Citraro, et al.. (2012). Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis. Neuroscience. 226. 282–288. 32 indexed citations
11.
Scicchitano, Francesca, Chiara Giofrè, Caterina Palleria, et al.. (2012). Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis.. PubMed. 17(9). 872–5. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026